Prospective follow-up of rituximab treatment in 158 patients with refractory autoimmune diseases: Tolerance and safety data from the french registry air (autoimmunity and rituximab)

被引：0

作者：

Gottenberg, J. ^{[1
]}

Combe, B. ^{[2
]}

Dougados, M. ^{[3
]}

Berthelot, J. ^{[4
]}

Hachullas, E. ^{[5
]}

Guillevins, L. ^{[6
]}

Pallot-Prades, B. ^{[7
]}

Costedoat-Chalumeaue, N. ^{[8
]}

DeBandt, M. ^{[9
]}

Sordet, C. ^{[10
]}

Fain, O. ^{[11
]}

Larroche, C. ^{[12
]}

Gaudin, P. ^{[13
]}

Ardizzonne, M. ^{[14
]}

Somogyi, A. ^{[15
]}

Quartier, P. ^{[16
]}

Mariette, X.

机构：

[1] Bicetre Hosp Le Kremlin, Le Kremlin Bicetre, France

[2] Peyronie Hosp, Montpellier, France

[3] Cochin Hosp, Paris, France

[4] Nantes Hosp, Nantes, France

[5] Lille Hosp, Lille, France

[6] Cochin Hosp, Paris, France

[7] St Etienne Hosp, St Etienne, France

[8] La Pitie Salpetriere Hosp, Paris, France

[9] Robert Ballanger Hosp, Aulnay Sous Bois, France

[10] Strasbourg Hosp, Strasbourg, France

[11] Internal Med Jean Verdier Hosp, Bondy, France

[12] Avicenne Hosp, Bobigny, France

[13] Grenoble Hosp, Grenoble, France

[14] Mulhouse Hosp, Mulhouse, France

[15] St Germain Laye Hosp, St Gernmain En Laye, France

[16] Hop Necker Enfants Malad, Paris, France

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：431 / 431

页数：1

共 50 条

[41] LONG-TERM FOLLOW-UP OF PATIENTS WITH RHEUMATIC DISEASES AND SARS-CoV-2 INFECTION: DATA FROM THE SAR-COVID REGISTRY [J].

Isnardi, C. A. ;

Alfaro, M. A. ;

Virasoro, B. M. ;

Gomez, G. ;

D'angelo, M. E. ;

Saurit, V. ;

Petkovic, I. E. ;

Quintana, R. ;

Tissera, Y. ;

Pisoni, C. ;

Berbotto, G. ;

Salinas, M. Haye ;

Ornella, S. ;

Pera, M. ;

Reyes, A. A. ;

Baez, R. ;

Pereira, D. A. ;

Alle, G. ;

Coello, V. V. Castro ;

Alba, P. ;

Cogo, A. K. ;

Alonso, C. G. ;

Gobbi, C. ;

Yanzi, J. Gallino ;

Pons-Estel, G. .

ANNALS OF THE RHEUMATIC DISEASES, 2024, 83

[42] Medical treatment of cardiovascular diseases in patients after hospitalization for COVID-19 (three-year follow-up data in the TARGET-VIP registry) [J].

Kutishenko, N. P. ;

Martsevich, S. Yu. ;

Loukianov, M. M. ;

Andreenko, E. Yu. ;

Voronina, V. P. ;

Dindikova, V. A. ;

Dmitrieva, N. A. ;

Kudryavtseva, M. M. ;

V. Lerman, O. ;

Okshina, E. Yu. ;

Smirnov, A. A. ;

Soplenkova, A. G. ;

Pulin, A. A. ;

Kuzina, N. N. ;

Nefedova, D. A. ;

Klyashtorniy, V. G. ;

Karpov, O. E. ;

Drapkina, O. M. .

RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2024, 20 (06)

[43] Secukinumab demonstrates sustained effectiveness and safety in patients with moderate to severe plaque psoriasis: 30-month follow-up data from the PURE registry [J].

Papp, Kim ;

Gooderham, Melinda ;

Haydey, Richard ;

Alam, Maryam Shayesteh ;

Brassard, Danielle ;

Delorme, Isabelle ;

Loo, Wei-Jing ;

Rao, Jaggi ;

Wasel, Norman ;

Vieira, Antonio ;

Rihakova, Lenka .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) :AB95-AB95

[44] Rituximab-Based Regimen As First-Line Treatment in Chinese Patients with Follicular Lymphoma: Three-Year Safety Data from a Prospective, Observational Study [J].

Wu, Jianqiu ;

Song, Yongping ;

Su, Liping ;

Zhang, Mingzhi ;

Li, Wei ;

Hu, Yu ;

Zhang, Xiaohong ;

Gao, Yuhuan ;

Niu, Zuoxing ;

Feng, Ru ;

Wang, Wei ;

Peng, Jiewen ;

Li, Xiaolin ;

Ouyang, Xuenong ;

Wu, Changping ;

Zhang, Weijing ;

Zeng, Yun ;

Xiao, Zhen ;

Liang, Yingmin ;

Zhuang, Yongzhi ;

Wang, Jishi ;

Sun, Zimin ;

Bai, Hai ;

Cui, Tongjian ;

Feng, Jifeng .

BLOOD, 2017, 130

[45] Secukinumab treatment results in improvement of disease characteristics in patients with moderate to severe psoriasis: 24 month follow-up data from the PURE registry [J].

Papp, Kim A. ;

Gooderham, Melinda ;

Alavi, Afsaneh ;

Brassard, Danielle ;

Wasel, Norman ;

Rao, Jaggi ;

Loo, Wei-Jing ;

Rampakakis, Emmanouil ;

Vieira, Antonio ;

Rihakova, Lenka .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) :AB274-AB274

[46] Use of Rituximab Compared to Anti-TNF Agents As Second and Third Line Therapy in Patients with Rheumatoid Arthritis: 6-Year Follow-up Report from the Rhumadata® Clinical Database and Registry [J].

Choquette, Denis ;

Bessette, Louis ;

Haraoui, Boulos ;

Massicotte, Frederic ;

Pelletier, Jean-Pierre ;

Raynauld, Jean-Pierre ;

Remillard, Marie-Anais ;

Sauvageau, Diane ;

Villeneuve, Edith ;

Coupal, Louis ;

Brown, Jacques ;

Turcotte, Angele .

ARTHRITIS & RHEUMATOLOGY, 2015, 67

[47] Use of Rituximab Compared to Anti-TNF Agents as Second and Third Line Therapy in Patients with Rheumatoid Arthritis. A 6 Year Follow-Up Report from the Rhumadata Clinical Database and Registry [J].

Choquette, Denis ;

Bessette, Louis ;

Brown, Jacques ;

Haraoui, Boulos ;

Massicotte, Frederic ;

Pelletier, Jean-Pierre ;

Raynauld, Jean-Pierre ;

Remillard, Marie-Anais ;

Sauvageau, Diane ;

Villeneuve, Edith ;

Coupal, Louis .

JOURNAL OF RHEUMATOLOGY, 2016, 43 (06) :1212-1213

[48] Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry [J].

Tapete, Gherardo ;

Bertani, Lorenzo ;

Pieraccini, Alberto ;

Lynch, Erica Nicola ;

Giannotta, Martina ;

Morganti, Riccardo ;

Biviano, Ivano ;

Naldini, Sara ;

Mumolo, Maria Gloria ;

De Nigris, Francesca ;

Calella, Francesca ;

Bagnoli, Siro ;

Minciotti, Moira ;

Maltinti, Simona ;

Rentini, Silvia ;

Ceccarelli, Linda ;

Lionetti, Paolo ;

Milla, Monica ;

Costa, Francesco .

INFLAMMATORY BOWEL DISEASES, 2022, 28 (01) :62-69

[49] Validation of a risk prediction model for early chronic kidney disease in patients with type 2 diabetes: Data from the German/Austrian Diabetes Prospective Follow-up registry [J].

Kress, Stephan ;

Bramlage, Peter ;

Holl, Reinhard W. ;

Moeller, Christian Dominik ;

Muehldorfer, Steffen ;

Reindel, Joerg ;

Seufert, Jochen ;

Landgraf, Rudiger ;

Merker, Ludwig ;

Meyhoefer, Sebastian M. ;

Danne, Thomas ;

Fasching, Peter ;

Mertens, Peter R. ;

Wanner, Christoph ;

Lanzinger, Stefanie .

DIABETES OBESITY & METABOLISM, 2023, 25 (03) :776-784

[50] INCIDENCE OF FIRST CARDIOVASCULAR EVENT IN SPANISH PATIENTS WITH CHRONIC INFLAMMATORY RHEUMATIC DISEASES: PROSPECTIVE DATA FROM THE CARMA PROJECT AFTER 5 YEARS OF FOLLOW-UP [J].

Martin-Martinez, M. A. ;

Castaneda, S. ;

Sanchez-Alonso, F. ;

Garcia Gomez, C. ;

Gonzalez Juanatey, C. ;

Belmonte, M. A. ;

Tornero, J. ;

Santos Rey, J. ;

Sanchez Gonzalez, O. ;

Quesada-Masachs, E. ;

Moreno Gil, M. D. ;

Cobo-Ibanez, T. ;

Pinto Tasende, J. A. ;

Babio, J. ;

Bonilla, G. ;

Mas, A. J. ;

Manero, J. ;

Romera, M. ;

Bachiller-Corral, J. ;

Chamizo Carmona, E. ;

Calvo, J. ;

Sanmarti, R. ;

Erausquin, M. C. ;

Garcia de Vicuna, R. ;

Barbadillo, C. ;

Ros Exposito, S. ;

Del Pino, J. ;

Gonzalez, M. J. ;

Pina Salvador, J. M. ;

Llorca, J. ;

Gonzalez-Gay, M. A. .

ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 :2-2

← 1 2 3 4 5 →